α‐Synuclein seed amplification assay detects Lewy body co‐pathology in autosomal dominant Alzheimer’s disease late in the disease course and dependent on Lewy pathology burden

by | Friday, April 26, 2024 | Dementia

Abstract INTRODUCTION Amyloid beta and tau pathology are the hallmarks of sporadic Alzheimer’s disease (AD) and autosomal dominant AD (ADAD). However, Lewy body pathology (LBP) is found in ≈ 50% of AD and ADAD brains. METHODS Using an α-synuclein seed...

Efficacy of Walking Adaptability Training on Walking Capacity in Ambulatory People With Motor Incomplete Spinal Cord Injury: A Multicenter Pragmatic Randomized Controlled Trial

by | Thursday, April 25, 2024 | Neurorehabilitation

Neurorehabilitation and Neural Repair, Volume 38, Issue 6, Page 413-424, June 2024. Background and ObjectiveBalance and walking capacity are often impaired in people with motor incomplete spinal cord injury (iSCI), frequently resulting in reduced functional ambulation...